Search Results

Refine Search

News & Features

Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025

Asia

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP 15 October 2024

Asia

How to navigate patent term adjustment in China

Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP. 8 October 2024

Americas

‘Masking only works for so long’: Working with ADHD

Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones. 1 August 2024

Big Pharma

Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism

Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details. 19 March 2024

Americas

UKIPO rejects Boehringer’s SPC for horse inhaler

Office declined application, citing earlier authorisations for inhalers designed for people containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not previously authorised for a veterinary product in the EU. 8 July 2025

Americas

WilmerHale gains partner with ‘deep expertise’

New addition expected to strengthen firm’s foundational ‘IP’ practice in Palo Alto. 8 July 2025

Americas

Bayer, Orion take on Indian generic over $117bn drug

German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer blockbuster | Suit follows leadership shakeup at Bayer. 8 July 2025

Europe

‘We created law’: G1/24 and the creation of the ‘diamond standard’

The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips 3 July 2025

Europe

BMS unit loses cell therapy patent at European Patent Office

Board of Appeal upholds opposition challenge over added subject-matter claims | Dispute concerned patent relating to T cell therapeutic manufacturing methods. 3 July 2025